Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical outcome of COVID-19 in patients with adult congenital heart disease.
Schwerzmann M, Ruperti-Repilado FJ, Baumgartner H, Bouma B, Bouchardy J, Budts W, Campens L, Chessa M, Del Cerro Marin MJ, Gabriel H, Gallego P, Garcia-Orta R, Gonzalez AE, Jensen AS, Ladouceur M, Miranda-Barrio B, Morissens M, Pasquet A, Rueda J, van den Bosch AE, van der Zwaan HB, Tobler D, Greutmann M; EPOCH. Schwerzmann M, et al. Among authors: ladouceur m. Heart. 2021 Jul 12;107(15):1226-1232. doi: 10.1136/heartjnl-2020-318467. Heart. 2021. PMID: 33685931 Free PMC article.
Is a planned caesarean section in women with cardiac disease beneficial?
Ruys TP, Roos-Hesselink JW, Pijuan-Domènech A, Vasario E, Gaisin IR, Iung B, Freeman LJ, Gordon EP, Pieper PG, Hall R, Boersma E, Johnson MR; ROPAC investigators. Ruys TP, et al. Heart. 2015 Apr;101(7):530-6. doi: 10.1136/heartjnl-2014-306497. Epub 2014 Dec 24. Heart. 2015. PMID: 25539946
Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study.
Yang H, Bouma BJ, Dimopoulos K, Khairy P, Ladouceur M, Niwa K, Greutmann M, Schwerzmann M, Egbe A, Scognamiglio G, Budts W, Veldtman G, Opotowsky AR, Broberg CS, Gumbiene L, Meijboom FJ, Rutz T, Post MC, Moe T, Lipczyńska M, Tsai SF, Chakrabarti S, Tobler D, Davidson W, Morissens M, van Dijk A, Buber J, Bouchardy J, Skoglund K, Christersson C, Kronvall T, Konings TC, Alonso-Gonzalez R, Mizuno A, Webb G, Laukyte M, Sieswerda GTJ, Shafer K, Aboulhosn J, Mulder BJM. Yang H, et al. Among authors: ladouceur m. Int J Cardiol. 2020 Jan 15;299:123-130. doi: 10.1016/j.ijcard.2019.06.014. Epub 2019 Jun 13. Int J Cardiol. 2020. PMID: 31307847 Free article.
Safety and efficacy of non-vitamin K antagonist oral anticoagulants for prevention of thromboembolism in adults with systemic right ventricle: Results from the NOTE international registry.
Scognamiglio G, Fusco F, Hankel TC, Bouma BJ, Greutmann M, Khairy P, Ladouceur M, Dimopoulos K, Niwa K, Broberg CS, Miranda B, Budts W, Bouchardy J, Schwerzmann M, Lipczyńska M, Tobler D, Tsai SF, Egbe AC, Aboulhosn J, Fernandes SM, Garr B, Rutz T, Mizuno A, Proietti A, Alonso-Gonzalez R, Mulder BJM, Sarubbi B; non-vitamin K antagonist oral anticoagulants for thromboembolic prevention in adult congenital heart disease (NOTE) registry Investigators. Scognamiglio G, et al. Among authors: ladouceur m. Int J Cardiol. 2021 Jan 1;322:129-134. doi: 10.1016/j.ijcard.2020.08.034. Epub 2020 Aug 14. Int J Cardiol. 2021. PMID: 32805330
280 results